As of 2026-04-19, the Intrinsic Value of Extendicare Inc (EXE.TO) is 32.26 CAD. This EXE.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 29.78 CAD, the upside of Extendicare Inc is 8.30%.
The range of the Intrinsic Value is 21.97 - 64.11 CAD
Based on its market price of 29.78 CAD and our intrinsic valuation, Extendicare Inc (EXE.TO) is undervalued by 8.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 21.97 - 64.11 | 32.26 | 8.3% |
| DCF (Growth 10y) | 30.25 - 85.16 | 43.74 | 46.9% |
| DCF (EBITDA 5y) | 18.62 - 40.12 | 29.67 | -0.4% |
| DCF (EBITDA 10y) | 25.45 - 52.58 | 38.74 | 30.1% |
| Fair Value | 25.58 - 25.58 | 25.58 | -14.10% |
| P/E | 21.65 - 29.53 | 25.89 | -13.1% |
| EV/EBITDA | 9.48 - 31.35 | 19.67 | -34.0% |
| EPV | 7.81 - 10.43 | 9.12 | -69.4% |
| DDM - Stable | 10.98 - 40.34 | 25.66 | -13.8% |
| DDM - Multi | 20.11 - 55.21 | 29.23 | -1.9% |
| Market Cap (mil) | 2,813.02 |
| Beta | 0.49 |
| Outstanding shares (mil) | 94.46 |
| Enterprise Value (mil) | 2,795.28 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.40% |
| Cost of Debt | 4.25% |
| WACC | 6.93% |